xIPOmeter
Biocon Biologics
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to Biocon Biologics144
Biocon BiologicsBiocon Biologics: Biocon Biologics refinances 1.1 billion debt ...
The bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security package, ...
https://m.economictimes.com/markets/bonds/biocon-biologics-refinances-1-1-billion-debt-through-us-dollar-bonds-and-new-syndicated-facility/amp_articleshow/113893018.cmsBiocon BiologicsBiocon Biologics Announces New Dermatology Data to Be ...
PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced new dermatology data presented at the ...
https://www.prnewswire.com/news-releases/biocon-biologics-announces-new-dermatology-data-to-be-presented-at-eadv-congress-2024-302258032.htmlBiocon BiologicsBiocon Biologics is planning to raise $950 million through overseas ...
Biocon Biologics plans to raise $950 million through overseas bond sales to refinance a significant portion of its $1.2-billion debt from acquiring Viatris ...
https://m.economictimes.com/markets/bonds/biocon-biologics-is-planning-to-raise-950-million-through-overseas-bonds/amp_articleshow/113339578.cmsBiocon BiologicsBiocon Biologics Secures Market Entry for Bmab 1200, a Proposed ...
PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON),...
https://www.prnewswire.com/news-releases/biocon-biologics-secures-market-entry-for-bmab-1200-a-proposed-biosimilar-to-stelara-in-europe-uk-canada-and-japan-302233763.htmlBiocon BiologicsBiocon Biologics signs agreement with Janssen to market Bmab 1200
Biocon Biologics has reached a settlement and licence agreement with Janssen Biotech, Janssen Sciences Ireland and Johnson & Johnson (collectively called ...
https://finance.yahoo.com/news/biocon-biologics-signs-agreement-janssen-103307911.html
Show more (139)Investors4
Goldman Sachs
ADQTata CapitalTrue North